In vivo electrochemical evidence for simultaneous 5-HT and histamine release in the rat substantia nigra pars reticulata following medial forebrain bundle stimulation: In vivo electrochemical characterization of 5-HT by Hashemi, Parastoo et al.
5-hydroxytryptamine (5-HT) is an important neuromodulator
and dysfunctions of the 5-HT system are particularly well-
documented in neurological disorders such as anxiety and
depression (Petty et al. 1996). In vivo neurochemical mea-
surements of 5-HT are necessary for furthering our under-
standing of the mechanisms that govern these disorders, and
will improve their diagnosis and treatment. Microdialysis
studies have correlated in vivo basal level 5-HT changes to
behavioral and pharmacological manipulations (Rueter et al.
1997; Barnes and Sharp 1999). Basal 5-HT levels are
determined by numerous individual neurotransmission
events that are averaged in one microdialysis reading
(Robinson and Wightman 2007) and to fully understand
the mechanisms that underlie these slow changes requires
quantitative, subsecond endogenous 5-HT detection. This has
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Abstract
Exploring the mechanisms of serotonin [5-hydroxytryptamine
(5-HT)] in the brain requires an in vivo method that combines
fast temporal resolution with chemical selectivity. Fast-scan
cyclic voltammetry is a technique with sufficient temporal and
chemical resolution for probing dynamic 5-HT neurotrans-
mission events; however, traditionally it has not been possible
to probe in vivo 5-HT mechanisms. Recently, we optimized
fast-scan cyclic voltammetry for measuring 5-HT release and
uptake in vivo in the substantia nigra pars reticulata (SNR)
with electrical stimulation of the dorsal raphe nucleus (DRN) in
the rat brain. Here, we address technical challenges associ-
ated with rat DRN surgery by electrically stimulating 5-HT
projections in the medial forebrain bundle (MFB), a more
accessible anatomical location. MFB stimulation elicits 5-HT in
the SNR; furthermore, we find simultaneous release of an
additional species. We use electrochemical and pharmaco-
logical methods and describe physiological, anatomical and
independent chemical analyses to identify this species as
histamine. We also show pharmacologically that increasing
the lifetime of extracellular histamine significantly decreases
5-HT release, most likely because of increased activation of
histamine H-3 receptors that inhibit 5-HT release. Despite this,
under physiological conditions, we find by kinetic comparisons
of DRN and MFB stimulations that the simultaneous release of
histamine does not interfere with the quantitative 5-HT con-
centration profile. We therefore present a novel and robust
electrical stimulation of the MFB that is technically less chal-
lenging than DRN stimulation to study 5-HT and histamine
release in the SNR.
Keywords: fast-scan cyclic voltammetry, histamine N-meth-
yltransferase, medial forebrain bundle, serotonin, SKF 91488,
substantia nigra pars reticulata.
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traditionally been accomplished with fast-scan cyclic vol-
tammetry (FSCV) in tissue slice preparations (O’Connor and
Kruk 1991; Rice et al. 1994; Bunin and Wightman 1998;
John et al. 2006). These studies have provided a solid
understanding of 5-HT release and uptake kinetics (Bunin
et al. 1998), 5-HT receptor pharmacology (Davidson and
Stamford 1996; Threlfell et al. 2010), and 5-HT metabolism
by monoamine oxidase (John and Jones 2007). Recently,
FSCV has been used to perform similar characterizations in
D. melanogaster (Borue et al. 2009, 2010). While these
types of studies are essential to describe basic 5-HT
mechanisms, in vivo measurements in a mammalian brain
are necessary to understand how 5-HT dynamics are
modulated in the complex entity of the intact nervous
system. Recently we described a FSCV technique in which
carbon-fiber microelectrodes were coated with Nafion to
monitor 5-HT in vivo (Hashemi et al. 2009). The Nafion
modification reduces electrode fouling while increasing its
sensitivity to 5-HT. This is the first technique capable of
monitoring endogenous, in vivo 5-HT release and uptake on
a subsecond time scale. In this previous work, we established
a physiological model where we evoked 5-HT release with a
bipolar stimulating electrode in the dorsal raphe nucleus
(DRN), the location of 5-HT cell bodies, and recorded
terminal 5-HT release and uptake in the substantia nigra pars
reticulata (SNR) (Hashemi et al. 2009).
In this paper, we explore an alternative method of evoking
5-HT release in the SNR. Using the well-documented
efferent circuitry of the DRN (Azmitia and Segal 1978;
Moore et al. 1978; Parent et al. 1981; Imai et al. 1986), we
exploit a branched 5-HT projection to both the SNR and the
striatum (van der Kooy and Hattori 1980; Imai et al. 1986)
that is located in the medial forebrain bundle (MFB). We
previously showed that electrical stimulation of the MFB
released an unidentified substance in the red nucleus of the
rat that we suspected was 5-HT (Kita et al. 2009). This
suggested that MFB stimulation could evoke 5-HT release in
targets posterior to the stimulating electrode. Here, we
confirm this expectation by demonstrating that branched 5-
HT fibers can be retrogradely activated, allowing the
experimenter to avoid targeting the DRN, an anatomically
challenging surgical technique. However, we find that MFB
stimulation elicits release of an additional species in the
SNR. With electrochemical and pharmacological data, in
addition to literature documenting histamine’s physiological,
anatomical and independent chemical verification in the SNR
(Brown et al. 2001), we identify this substrate as histamine.
Threllfel et al. have previously shown that pharmacological
activation of H-3 receptors inhibits 5-HT release (Threlfell
et al. 2004). In accord with this, we find significant decreases
in 5-HT release upon administration of SKF 91488, an agent
that prolongs histamine lifetime in the synapse. With no drug
present, we compare the 5-HT concentration release and
uptake profiles between DRN and MFB stimulations and find
that histamine release does not interfere with the quantifica-
tion of the 5-HT signal. We thereby present a novel and
robust method for studying 5-HT and histamine neurotrans-
mission in the SNR.
Materials and methods
Animals
Male Sprague–Dawley rats, 8–12 weeks old, weighing 250–350 g,
were purchased from Charles River Labs (Raleigh, NC, USA). Rats
were housed under 12 h/12 h light cycles with controlled temper-
ature and humidity. Food and water were available ad libitum. All
animal care was in accordance with the Guide for the Care and Use
of Laboratory Animals and was approved by the Institutional
Animal Care and Use Committees of the University of North
Carolina.
Surgery
Rats were anesthetized with urethane (1.5 g/kg rat weight) and
positioned into a stereotaxic frame (David Kopf Instruments,
Tujunga, CA, USA). Holes were drilled in the skull according to
stereotaxic coordinates referenced from bregma and taken from
Paxinos and Watson’s Rat Brain Atlas (Paxinos and Watson 2007).
Nafion-modified carbon-fiber microelectrodes were implanted in the
SNR (stereotaxic coordinates AP )4.8 to )5.2; ML +2.0; DV )8.5).
A bipolar stainless steel stimulating electrode, insulated to the tip
(0.2 mm diameter, Plastics One, Roanoke, VA, USA) was implanted
into the MFB (AP )2.5 to )2.8; ML 1.7; DV )8.0) or DRN as
described previously (Hashemi et al. 2009). An Ag/AgCl wire
serving as a reference electrode was implanted into the contralateral
hemisphere. Computer-generated biphasic pulse trains were applied
through constant current stimulators (NL 800A, Neurolog, Medical
Systems Corp., Great Neck, NY, USA), 2 ms in width and 350 lA
each phase (unless otherwise noted), at 60 Hz for 2 s to evoke 5-HT
release.
Voltammetric procedures
Cylindrical carbon-fiber microelectrodes were constructed by
aspiration of a single 2.5-lm radius carbon fiber (T-650, Thornel,
Amoco Co, Greenville, SC, USA) into a glass capillary of 0.6 mm
external diameter and 0.4 mm internal diameter (A-M Systems, Inc.,
Sequim, WA, USA). A micropipette puller (Narishige, Tokyo,
Japan) was used to taper the glass and form a carbon-glass seal. The
exposed carbon fiber was cut to approximately 100 lm in length
and was soaked for 30 min in isopropyl alcohol to clean the surface.
The procedure for electrodeposition of Nafion was described
previously (Hashemi et al. 2009). Dopamine and 5-HT specific
electrochemical detection waveforms were used as described
elsewhere (Jackson et al. 1995; Heien et al. 2003). A customized
version of TH-1 software (ESA, Chelmsford, MA, USA) written in
LABVIEW (National Instruments, Austin, TX, USA) was used for
waveform generation and data acquisition. A custom-built UEI
potentiostat (University of North Carolina at Chapel Hill, Depart-
ment of Chemistry Electronics Facility) was employed. All
potentials are reported versus an Ag/AgCl reference electrode.
Signal processing [background subtraction, signal averaging, and
digital filtering (4-pole Bessel Filter, 5 kHz)] was also done in TH-1
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software. Voltammetric data are visualized as color plots that show
multiple background-subtracted cyclic voltammograms that were
consecutively collected. The abscissa is time and the current is
encoded as false color (Michael et al. 1998). For most of the work in
this paper, the ordinate is the voltage axis that peaks at 1.0 V, scans
back to )0.1 V and returns to 0.2 V, the rest potential. The
sensitivity with this waveform on Nafion modified microelectrodes
to 5-HT is 49.5 nA/lM and 0.4 nA/lM to histamine.
Histology
To verify the spatial placement of the electrodes in vivo, the carbon-
fiber microelectrode that acquired data was used to create a small,
specific lesion in the recording site by applying constant voltage
(20 V for 10 s) (Park et al. 2009). Following the experiment, rats
were killed and perfused with 10% formalin solution. Brains were
then removed from the skull and stored in 10% formalin. After at
least 3 days, the brains were flash-frozen, sectioned into 40 lm
slices in a cryostat, mounted on glass slides, and stained with 0.2%
thionine. The brains were visualized and photographed with an
optical microscope.
Drugs and reagents
Serotonin hydrochloride, histamine dihydrochloride and thio-
peramide maleate were obtained from Sigma-Aldrich (St. Louis,
MO, USA) at reagent quality and used without purification. SKF
91488 dihydrochloride was obtained from Tocris Bioscience
(Ellisville, MO, USA) and was delivered at a high dose to ensure
permeation across blood brain barrier and cause robust in vivo
effects (50 mg/kg). Drugs were dissolved in saline and were injected
intraperitoneally at a volume of 0.6 mL/kg.
Data analysis
Kinetic characterization of 5-HT release and uptake was adapted
from techniques previously used to describe kinetics of release and
uptake of the dopamine system (Garris and Wightman 1994).
Release was described as [5-HT]p*f, where [5-HT]p is the amount of
5-HT released per stimulation pulse, and f is the frequency of
stimulation pulses. The rate of change during stimulation is:
d[5-HT]
dt






in which the duration of the release term is determined by the
number of pulses in the stimulation. Only the uptake term dominates
after the stimulation terminates. The uptake rate of 5-HT from the
extra-cellular space (v) following electrically stimulated release was








Vmax is the maximal rate of uptake, and Km is the Michaelis–
Menten constant that describes the affinity of the 5-HT transporter
for 5-HT. It was taken to be 170 nM, a value found in rat brain
synaptosomes (Shaskan and Snyder 1970; Mosko et al. 1977).
In all simulations, analyte diffusion through a thin layer (300 nm)
of Nafion was accounted for (Kristensen et al. 1987). The amount of
5-HT released per stimulation pulse [(5-HT)p] and Km and Vmax
were determined by fitting the model to the experimental data. In
experiments involving transport inhibition, Vmax was fixed to values
determined in pre-drug models.
Student’s t-tests were performed on paired data sets, p < 0.05 was
taken as significant.
Flow injection analysis
For experiments characterizing histamine and 5-HT cyclic voltam-
metry in vitro, flow injection analysis was used (Kristensen et al.
1986). The carbon-fiber microelectrode was placed in the output of a
six-port HPLC loop injector mounted on a two-position actuator
(Rheodyne model 7010 valve and 5701 actuator), operated by a
12 V DC solenoid valve kit (Rheodyne, Rohnert Park, CA, USA).
The apparatus enabled the introduction of a rectangular pulse of
analyte to the microelectrode surface using a syringe infusion pump
(Harvard Apparatus model 940, Hollison, MA, USA) at a flow rate
of 2 mL/min.
For in vivo experiments, the recording electrode was used to
make a lesion in the tissue at the end of all experiments to verify its
placement histologically. The high voltage across the working
electrode used to achieve this necessarily over-oxidizes the carbon
surface altering its sensitivity. Therefore, post-calibrations would not
be a reliable measure of the electrode response. Rather, pre-
calibrations were used to obtain a calibration curve, as described
previously (Hashemi et al. 2009).
Results
Comparison of 5-HT following DRN or MFB stimulation
Histology verified the location of the stimulating and carbon-
fiber microelectrodes in coronal slices of brains used in
in vivo experiments (Fig. 1). The stimulating electrode was
in the MFB and the carbon-microelectrode was in the SNR as
indicated by the small lesions.
We have previously shown that electrical stimulation of
the DRN releases 5-HT in the SNR (Hashemi et al. 2009). In
Fig. 2, we compare this type of electrically stimulated 5-HT
release (Fig. 2a) to 5-HT release elicited via MFB stimula-
tion (Fig. 2b). The horizontal dashed lines in Fig. 2(a-iii) are
at the peak potential for 5-HT oxidation (0.65 V) (1) and
oxidation of an additional substrate (0.85 V) (2). The
currents at these potentials were converted to concentrations
and are plotted directly above this [(i) 5-HT, (ii) additional
substrate]. In Fig. 2(a-i), the current begins to rise at
stimulus initiation and peaks within 0.5 s of the stimulation
termination. In Fig. 2(a-ii), there is a small increase in
current in response to the stimulation. The vertical dashed
line in the color plot (Fig. 2a-iii) at the end of the stimulation
and the current at this time were used to construct the cyclic
voltammogram (inset). This cyclic voltammogram is iden-
tical to those obtained in vitro for 5-HT where the presence
of the reverse wave is characteristic of 5-HT. Similar results
were obtained with MFB stimulation (Fig. 2b). In Fig. 2(b-
i), the 5-HT current profile closely matches the 5-HT current
profile in Fig. 2(a-i), however, the current obtained upon
 2011 The Authors
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stimulation in Fig. 2(b-ii) is threefold greater with MFB
stimulation that with DRN stimulation. The cyclic voltam-
mogram (inset a) is taken at the vertical dashed line at the
end of the stimulation. An additional vertical dashed line (b)
is taken 2 s after the stimulus termination; the current at this
time was used to construct the cyclic voltammogram in inset
b. Panel (c) shows the averaged maximal release amplitudes
of (1) 5-HT and (2) the additional substrate as the stimulating
electrode is lowered down the dorsal/ventral tract above the
MFB (n = 6 ± SEM). For each line, the data are normalized
to the maximal signal along the stimulation track. When two
points are statistically different, the p-value is noted.
The concentration changes extracted from the current at
0.65 V exhibit a time-course in the SNR very similar to the
DRN stimulation. DRN and MFB averaged maximal
concentrations in the SNR are statistically identical:
12.7 ± 1.6 nM (n = 6 ± SEM) 5-HT with DRN stimulation
(Hashemi et al. 2009) and 12.8 ± 1.0 nM (n = 6 ± SEM)
with MFB (p = 0.29). Similarly, the time for 5-HT to be
cleared to one half of its maximal value (t1/2) is 1.7 ± 0.3 s
with DRN stimulation (n = 6 ± SEM) and 1.8 ± 0.2 s with
MFB stimulation (n = 6 ± SEM) (p = 0.45).
Examination of the color plot reveals additional features
around the time of the stimulation. An oxidation process at
0.85 V on the reverse scan accompanied by a reduction
process at 0.1 V are simultaneous with the 5-HT signal.
Because these processes disappear rapidly after the stimula-
tion, a cyclic voltammogram collected at 2 s after the
stimulation (inset b) has the characteristic 5-HT cyclic
voltammogram. However, when it is recorded at the end of
the stimulation (inset a), it has additional features. Because
5-HT is oxidized at a potential that is reached before the
additional species, the presence of the second species does
not distort the time-course of 5-HT detection.
Characterization of histamine cyclic voltammetry
The additional oxidation and reduction occur on the back-
wards oxidation scan and forwards reduction scan. This
indicates a kinetically limited reaction that is dependent on
the initial sweep that regenerates the electrode’s carbon
surface (Takmakov et al. 2010). The SNR is populated with
histaminergic terminals (Panula et al. 1989) and histamine
displays this type of kinetically limited electrochemistry as
demonstrated by following the direction of the potential
sweep with the arrows in Fig. 3. This figure compares in
vitro responses at a carbon-fiber microelectrode, using the 5-
HT waveform (see above) of (a) 5-HT (500 nM), (b)
histamine (20 lM), (c) 5-HT + histamine (500 nM + 20
lM, respectively) to (d) the in vivo response in the SNR
during MFB stimulation. Panel (i) shows the color plots and
panel (ii) shows the cyclic voltammograms taken at the white
dashed vertical lines. The microelectrode’s response to
histamine (20 lM) injected alone is 7.9 ± 0.9 nA (n = 4 ±
SEM) and to histamine (20 lM) injected with 5-HT is 7.5 ±
0.7 nA (n = 4 ± SEM) (p = 0.6). The features of the in vivo
response (d) are clearly electrochemically reproduced via a
5-HT + histamine mixture (c).
Figure 4 shows how the histamine signal changes with the
applied waveform. Figure 4(a) shows a log-log trace of the
current response (n = 5 ± SEM) in vitro to flow injections of
histamine (20 lM) as a function of increasing the scan rate of
the detection waveform. It can be seen that the histamine
response is proportional to the scan rate: the slope of the log-
log plot is 0.56 indicating diffusion-controlled electrochem-
istry. In Fig. 4(b), the peak amplitude for histamine oxidation
is shown as a function of increasing the positive limit of the
applied voltage. Increasing the potential window of the
detection waveform causes an increase in the histamine
response from 6.6 ± 2.2 nA (n = 5 ± SEM) at 1.2 V to
13.4 ± 3.7 nA (n = 5 ± SEM) at 1.3 V (p = 0.01). This
behavior has been seen previously for dopamine (Hafizi
et al. 1990). At the same time, the peak on the reverse scan
occurs at more positive potentials as the scan limit is
increased, shown by the inset cyclic voltammograms.
Responses to inhibition of histamine N-methyltransferase
Unlike most biogenic amine neurotransmitters, histamine is
not thought to be inactivated by a specific transporter (Brown
(a)
(b)
Fig. 1 Histology of stimulating and carbon-fiber electrode placements
in the MFB and SNR. Left hemisphere is a diagram showing intended
placement of (a) stimulation electrode in the MFB or (b) carbon fiber
microelectrode in the SNR at coordinates described in the methods
section. Right hemisphere shows actual placement in a representative
brain.
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Fig. 2 5-HT color plot, CV and time profile of response in SNR with
DRN and MFB stimulation. (a) and (b) – comparison of signals ob-
tained in SNR obtained following DRN and MFB electrical stimulation,
respectively. Concentrations vs. time taken at the horizontal white
dashed lines are shown above the color plots in panels (i) and (ii), and
representative cyclic voltammograms (vs. Ag/AgCl) taken at the ver-
tical white dashed lines are inset. (iii) Color plots show all of the
background corrected cyclic voltammetric data. Bipolar stimulation
onset at 5 s is 350 lA, 60 Hz and 120 pulses, represented by blue bar.
(c) shows averaged, normalized maximal release amplitude of 5-HT
(1) and the additional substrate (2) at 0.5 mm dorsal/ventral intervals
of the stimulating electrode (n = 6 ± SEM). Where the two values are
statistically different, the p-value is added.
Fig. 3 Comparison of in vivo signal to a mixed in vitro 5-HT and his-
tamine signal. In vitro injections of (a) 5-HT (500 nM), (b) histamine
(20 lM), or (c) 5-HT (500 nM) + Histamine (20 lM), and (d) in vivo
response shown in (i) color plot format and (ii) cyclic voltammograms.
Current is represented in false color and is a dual scale (left for in vitro
and right for in vivo). Representative cyclic voltammograms were
taken at the white dashed lines; in (d), the cyclic voltammogram was
taken at 0.5 s after stimulation duration, indicated by the white dashed
line. This position best captures both substrates.
 2011 The Authors
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et al. 2001). Instead, it is primarily inactivated by methyl-
ation, a process that is catalyzed by histamine N-methyl-
transferase. To pharmacologically verify the species detected
at more positive potentials as histamine, an inhibitor of
histamine N-methyltransferase, SKF 91488 (50 mg/kg) was
administered. SKF 91488 is a potent, non-competitive
inhibitor of histamine N-methyltransferase that is inactive
at histamine receptors (Beaven and Shaff 1979). Panel (i) of
Fig. 5 displays the effects of this agent in one rat. Figure 5(a)
shows the average color plot of five control stimulations,
taken 10 min apart. Figure 5(b) shows the average color plot
of five stimulations 1 h after drug administration, taken
10 min apart. Horizontal white dashed lines a and b were
used to construct concentration vs. time plots of histamine
(a) and 5-HT (b) which were then averaged for five animals
and displayed in panel (ii) (n = 5 ± SEM). The control
responses are shown in blue and the drug responses are
shown in black. Electrically stimulated histamine release was
2.8 ± 1.3 lM (n = 5 ± SEM). After drug administration, the
half-decay time (t½) for histamine was significantly increased
from 4.1 ± 0.9 s to 10.4 ± 2.1 s (p = 0.03) with no change
in amplitude. The maximal evoked concentration of 5-HT
decreased from 9.3 ± 1.0 nM to 4.6 ± 0.4 nM (p = 0.01)
without a change in its t½ value. Panel (iii) of Fig. 5 shows
the effects of SKF 91488 on 5-HT release amplitude in
control rats (a) (n = 5 ± SEM) and in rats pre-treated with
thioperamide (10 mg/kg) (n = 6 ± SEM), a selective H-3
receptor antagonist (b). In rats pre-treated with thioperamide,
5-HT release is not significantly affected after SKF 91488
administration; the control response was 10.2 ± 1.3 nM and
10.4 ± 1.5 nM after SKF 91488 administration (p = 0.76).
Modeling 5-HT release and uptake
Figure 6 compares experimental and modeled 5-HT data
between the two stimulations. The experimental data (blue
dots) are superimposed on the model (black line). The model
is a composite of linear release and uptake governed by
Michaelis–Menten kinetics (Wightman et al. 1988). The
concentration of 5-HT released per stimulation pulse,
[5-HT]p, and the maximal uptake velocity, Vmax, were
adjusted for the best fit while the value of the Km for uptake
was fixed at 170 nM. During DRN stimulation, the model
yields [5-HT]p of 1.5 nM and a Vmax of 0.63 lM/s, and
during MFB stimulation, the model yields [5-HT]p of
1.1 nM, with a Vmax of 0.67 lM/s.
Discussion
Electrical MFB stimulation evokes 5-HT release in the SNR
The efferent circuitry of the DRN to the SNR is well-
documented (Dray et al. 1976; Fibiger and Miller 1977;
Wirtshafter et al. 1987; Corvaja et al. 1993), as are its
projections to the striatum (Miller et al. 1975; Steinbusch
et al. 1980, 1981). Some studies, including a retrograde
labeling study by Van der Kooy et al., show that the same 5-
HT projection branches to both the SNR and the striatum
(van der Kooy and Hattori 1980; Imai et al. 1986). Striatal
bound 5-HT fibers travel within the MFB (Miller et al.
1975). If axonal stimulation in the MFB could be used in
place of DRN stimulation, certain experimental challenges
associated with DRN stimulation can be avoided. These
challenges arise primarily from the small size, inaccessible
Fig. 4 Effect of varying scan rate and upper potential limit on hista-
mine response in vitro. (a) Log-log current response to in vitro injec-
tions of histamine (20 lM) as the waveform scan rate is increased
from 100 V/s to 2000 V/s with conventional 5-HT waveform (0.2–
1.0 V) (n = 5 ± SEM), where the line of best fit is a linear regression.
(b) Current response to in vitro injections of histamine (20 lM) as the
upper potential window is increased from 0.9 V to 1.4 V (n = 5 ± SEM)
vs. Ag/AgCl. Representative cyclic voltammograms are inset at 1.0,
1.3 and 1.4 V.
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location and complicated topography of the DRN (Whishaw
et al. 1977; Dib 1994). However, before this work, it had not
been established whether electrical stimulation of the MFB at
a location anterior to the terminal site (SNR) would release 5-
HT. We had previously reported a similar phenomenon: the
release of an unidentified substance in the red nucleus
terminals upon anterior stimulation of the MFB (Kita et al.
2009). We suspected this substance was 5-HT, but since we
had not yet optimized our electrochemical detection method
with Nafion, we were unable to electrochemically verify this.
Fig. 5 Pharmacological characterization of
histamine with SKF 91488. (i) Color plots
showing electrically stimulated response in
the SNR in (a) control and (b) 1 h after intra-
peritoneal SKF 91488 (50 mg/kg) adminis-
tration. (ii-a) Averaged concentration vs.
time responses taken at oxidation potential
a in control (blue) and 1 h after intra-peri-
toneal SKF 91488 (50 mg/kg) administra-
tion (black) (n = 5 ± SEM). (ii-b) Averaged
concentration vs. time responses taken at
oxidation potential b in control (blue) and
1 h after intra-peritoneal SKF 91488
(50 mg/kg) administration (black) (n = 5 ±
SEM). The blue bars represent the dura-
tions of the stimulus (350 lA, 60 Hz and
120 pulses) and error bars are SEM. (iii)
Averaged maximal 5-HT release concen-
tration in control rats (a) and rats pre-trea-
ted with thioperamide (10 mg/kg) (b). The
bars are averages of the maximal 5-HT re-
lease in control stimulations (blue) and after
SKF 91488 (50 mg/kg) administration
(n = 6 ± SEM).
(a) (b)
Fig. 6 A comparison of 5-HT experimental data and kinetic analysis
between DRN and MFB stimulation. Averaged, normalized experi-
mental data evoked by a 350 lA, 60 Hz and 120 pulse stimulation of
the DRN (a) and the MFB (b) (blue dots, n = 6 ± SEM). Kinetically
modeled data (black line) is superimposed and kinetic parameters
Vmax and [5-HT]p are inset when Km is fixed at 170 nM. Blue box
indicates duration of stimulation and error bars are SEM.
 2011 The Authors
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Because of our recent technological advances for in vivo 5-
HT detection (Hashemi et al. 2009), we are able to study
whether this phenomenon applies to 5-HT release in the SNR
with MFB stimulation.
In Fig. 2, we compare the terminal output in the SNR upon
DRN and MFB stimulation. Comparison of the inset cyclic
voltammograms electrochemically confirms that 5-HT is
released upon MFB stimulation. However, another substrate
is present in the MFB cyclic voltammogram in Fig. 2(b). The
main reductive process of 5-HT is delayed with both DRN and
MFB stimulation and indeed in in vitro (inset b). However, the
reduction associated with the other substrate occurs simulta-
neously with the oxidation (inset a) showing this substrate is
electrochemically independent from 5-HT. While the second
substrate overlaps with the voltammograms for 5-HT, it does
not interfere with the concentration of 5-HT obtained at
0.65 V because its electrolysis peaks occur later in the cyclic
voltammogram. We have previously found somatodendritic
dopamine release in the ventral tegmental area upon MFB
stimulation (Kita et al. 2009), however, because of the low
levels of dopamine in the SNR (Heeringa and Abercrombie
1995) and the low sensitivity of the 5-HTspecific waveform to
dopamine (Hashemi et al. 2009), it is unlikely that there is a
significant contribution from dopamine to this signal.
Moreover, we had previously shown that the signal in the
SNR is unresponsive to pharmacological manipulations by
a dopamine transporter inhibitor, GBR 12909, when we
stimulate the DRN (Hashemi et al. 2009). We also con-
firmed this to be true for MFB stimulation (data not shown).
Histamine is simultaneously released with 5-HT in the SNR
during MFB stimulation
The oxidation and reduction peaks of the additional substrate
occur on the backward sweep of the oxidation scan and the
forward sweep of the reduction scan. Such features have
been previously seen in fast-scan cyclic voltammetry (Pihel
et al. 1995), and they are indicative of an electrochemical
process that requires electrochemical cleaning of the elec-
trode prior to its oxidation. Possible candidates based on
these electrochemical characteristics are histamine, adeno-
sine, or hydrogen peroxide (Pihel et al. 1998; Cechova and
Venton 2008; Sanford et al. 2010). All three of these
compounds are oxidized at very positive potentials and
could be released by electrical stimulation of the medial
forebrain bundle. We have previously shown that 5-HT itself
can have distorted peaks when the electrode surface is
fouled, but Nafion electrodeposition employed in our tech-
nique minimized this effect (Hashemi et al. 2009). Addi-
tionally, some groups have found ‘switching’ artifacts that
occur at the switching potential of the waveform (Bull et al.
1990). The small current obtained at 0.85 V in Fig. 2(a-ii)
may have contributions by such a switching artifact at around
1 V, however, the equivalent MFB stimulation causes a much
larger current at 0.85 V (Fig. 2b-ii).
Collectively, the evidence presented in this paper indicates
that histamine is the substance detected along with 5-HT.
Histaminergic projections originate from the tuberomamm-
illary nucleus (TM), located immediately ventral to the MFB,
and traverse the MFB (Garbarg et al. 1974, 1976; Kohler
et al. 1985; Panula et al. 1989). One of the target regions is
the SNR where dense populations of histamine containing
nerve terminals and histaminergic receptors are found
(Panula et al. 1989; Schwartz et al. 1991). High amounts
of histamine and histidine decarboxylase, the enzyme
responsible for histamine synthesis from histidine, have been
chemically verified in the SNR using microenzymatic
methods (Pollard et al. 1978). Furthermore, the H-3 recep-
tors present in the SNR (Cumming et al. 1991; Pollard et al.
1993; Anichtchik et al. 2000) have been shown to modulate
GABA and 5-HT dynamics (Garcia et al. 1997; Korotkova
et al. 2002; Threlfell et al. 2004). Thus, histamine release in
the SNR following MFB stimulation is an anticipated result.
Given the close locality of these two locations (MFB and
TM), it is not possible to selectively stimulate the TM
without activating the MFB. Thus, to gain more insight into
the nature of the stimulation, we recorded maximal 5-HT and
histamine release in the SNR while we lowered the
stimulating electrode down the dorsal/ventral tract above
our MFB coordinates in 0.5-mm intervals from 5.5 mm to
10 mm. Figure 2(c) shows that the maximal response for
both 5-HT and histamine are at D/V 8.5 mm (n = 6 ± SEM)
which is not surprising since this is the dorsal/ventral
location of the MFB. However, the histamine response
significantly peaks earlier than the 5-HT response dorsal to
this location. This implies that the histaminergic fibers have a
broader and independent fiber distribution through the MFB
than the 5-HT fibers. In contrast to the MFB, the DRN has
very little histaminergic innervation (Panula et al. 1989),
explaining why stimulation of this region causes 5-HT
release in the SNR with little or no histamine release.
Further evidence that the additional species is histamine
comes from our electrochemical and pharmacological exper-
iments. First, as shown in Fig. 3, the cyclic voltammetry of
the unknown species closely resembles that for histamine in
pH 7.4 solution. Second, administration of the highly
selective ligand, SKF 91488, which potently inhibits hista-
mine N-methyltransferase (Beaven and Shaff 1979), signif-
icantly increased the clearance time of the signal in
comparison to the control with no effect on the signal
amplitude [Panel (ii-a) of Fig. 5]. This drug also caused a
significant decrease in the release amplitude of 5-HT after
drug administration (b). Prior work has shown that activation
of H-3 receptors inhibits 5-HT release (Threlfell et al. 2004).
Since SKF 91488 prolongs histamine’s life-time in the
extracellular space, this would result in increased activation
of H-3 receptors and suppression of 5-HT release. We
confirm this by pre-treating rats with thioperamide (10 mg/
kg), a highly selective H-3 receptor antagonist (Arrang et al.
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1987) prior to SKF 91488 administration. Panel (iii) of Fig. 5
shows that thioperamide pre-treatment significantly arrests
the SKF 91488 mediated inhibition of 5-HT release
(n = 6 ± SEM).
Thus, on the basis of electrochemical, anatomical, phys-
iological, and pharmacological evidence, we assign the
second signal simultaneously released upon MFB stimulation
to histamine.
The dynamic rate of electrically stimulated 5-HT release is
independent of DRN or MFB stimulation
To confirm that MFB and DRN stimulations evoke release
from a similar population of terminals in the SNR, we
compared 5-HT signals obtained with each stimulation and
compared kinetic parameters based on a model previously
used to characterize 5-HT release in brain slices containing
the SNR (Bunin and Wightman 1998). Figure 6 illustrates
that there are no significant differences in [5-HT]p or Vmax
in the SNR with stimulation of the DRN or MFB.
Furthermore, the calculated values of Vmax in the SNR
with both types of stimulation (0.63 and 0.67 lM/s,
respectively) agree with ones previously established in
tissue slice preparations (0.57 lM/s) (Bunin et al. 1998).
Since Vmax is a function of the number of active transport-
ers, this term is expected to be the same in slices and in
vivo. Thus, our finding of similar maximal uptake rates for
5-HT is consistent with removal of 5-HT by a transporter in
each preparation.
However, these quantitative modeling studies reveal that
5-HT release evoked in vivo is much smaller than evoked in
tissue slice preparations ([5-HT]p = 55 nM in slices contain-
ing the SNR (Bunin et al. 1998) but 1.5 nM in vivo with
MFB stimulation). This large difference in release amplitude
may have contributed to the previous physical and analytical
challenges of in vivo 5-HT voltammetric detection. It would
appear that the local stimulations that were employed in the
tissue slice preparation, bypassed the regulatory mechanisms
that tightly control 5-HT release in vivo. This suggests that
intact in vivo physiological mechanisms, combining both cell
body and terminal feedback, may profoundly regulate 5-HT
release. This regulation may be at the level of 5-HT
autoreceptors (Blier et al. 1998; Daws et al. 2000), release
of different vesicular pools (Pellegrino de Iraldi 1992), or
activation of other inhibitory mechanisms (Invernizzi et al.
2007). These regulatory mechanisms, in combination with
the fact that there is no known transporter for histamine, may
also explain why the magnitude of histamine release is far
greater than 5-HT release. These mechanisms are the focus of
our ongoing studies.
In conclusion, this work shows that 5-HT release can be
evoked by stimulating a collateral 5-HT projection in the
MFB that branches to both the SNR and the striatum. We
verified electrochemically, anatomically, physiologically and
chemically that the additional species present upon MFB is
histamine. We confirmed that MFB stimulation evokes 5-HT
release that is quantitatively equivalent to that evoked by
DRN stimulation; however, in both models, release is
profoundly less than in tissue slice culture experiments. This
highlights the importance of in vivo methods in exploring the
mechanisms of 5-HT.
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